Oral anticoagulants in patients with variable renal function

Abstract

The ongoing use of direct oral anticoagulant therapy versus warfarin in individuals with varying renal function is challenging. The degree of renal function variability, the context in which renal function changes occur, and other patient and provider-specific factors must be carefully evaluated when assessing the benefits and risks of ongoing direct oral anticoagulant therapy.